255 related articles for article (PubMed ID: 20102366)
1. Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery.
Gakis G; Schilling D; Bedke J; Sievert KD; Stenzl A
BJU Int; 2010 Feb; 105(4):468-71. PubMed ID: 20102366
[TBL] [Abstract][Full Text] [Related]
2. Incidental prostate cancer in radical cystoprostatectomy specimens.
Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.
Abdelhady M; Abusamra A; Pautler SE; Chin JL; Izawa JI
BJU Int; 2007 Feb; 99(2):326-9. PubMed ID: 17026595
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens.
Winkler MH; Livni N; Mannion EM; Hrouda D; Christmas T
BJU Int; 2007 Mar; 99(3):554-8. PubMed ID: 17407514
[TBL] [Abstract][Full Text] [Related]
5. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
[TBL] [Abstract][Full Text] [Related]
6. Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function.
Davila HH; Weber T; Burday D; Thurman S; Carrion R; Salup R; Lockhart JL
BJU Int; 2007 Nov; 100(5):1026-9. PubMed ID: 17868423
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the distance between the neurovascular bundle and prostate cancer foci in radical prostatectomy specimens: its clinical implication in nerve-sparing surgery.
Inoue S; Shiina H; Hiraoka T; Mitsui Y; Sumura M; Urakami S; Igawa M
BJU Int; 2009 Oct; 104(8):1085-90. PubMed ID: 19388988
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
9. [Prostate-sparing cystectomy: long-term functional and oncological results in a series of 25 cases].
Saidi A; Nahon O; Daniel L; Lay F; Lechevallier E; Coulange C
Prog Urol; 2004 Apr; 14(2):172-7; discussion 176. PubMed ID: 15217130
[TBL] [Abstract][Full Text] [Related]
10. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
Weizer AZ; Shah RB; Lee CT; Gilbert SM; Daignault S; Montie JE; Wood DP
Urol Oncol; 2007; 25(6):460-4. PubMed ID: 18047952
[TBL] [Abstract][Full Text] [Related]
13. Prostatic capsule and seminal vesicle-sparing cystectomy: improved functional results, inferior oncologic outcome.
Simone G; Papalia R; Leonardo C; Sacco R; Damiano R; Guaglianone S; Forastiere E; Gallucci M
Urology; 2008 Jul; 72(1):162-6. PubMed ID: 18372008
[TBL] [Abstract][Full Text] [Related]
14. Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients.
Botto H; Sebe P; Molinie V; Herve JM; Yonneau L; Lebret T
BJU Int; 2004 Nov; 94(7):1021-5. PubMed ID: 15541120
[TBL] [Abstract][Full Text] [Related]
15. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
16. Potency preserving cystectomy with intrafascial prostatectomy for high risk superficial bladder cancer.
Puppo P; Introini C; Bertolotto F; Naselli A
J Urol; 2008 May; 179(5):1727-32; discussion 1732. PubMed ID: 18343421
[TBL] [Abstract][Full Text] [Related]
17. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer.
Ruffion A; Manel A; Massoud W; Decaussin M; Berger N; Paparel P; Morel-Journel N; Lopez JG; Champetier D; Devonec M; Perrin P
Urology; 2005 Apr; 65(4):703-7. PubMed ID: 15833512
[TBL] [Abstract][Full Text] [Related]
18. Seminal vesicle-sparing perineal radical prostatectomy improves early functional results in patients with low-risk prostate cancer.
Albers P; Schäfers S; Löhmer H; de Geeter P
BJU Int; 2007 Nov; 100(5):1050-4. PubMed ID: 17760889
[TBL] [Abstract][Full Text] [Related]
19. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
20. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
